"Following CDC recommendations, anyone entering this facility must wear a mask. If you do not have one, we will provide you with a mask if necessary and available. Please stay informed with the latest on COVID-19 by visiting our website. Get care without leaving home by using our website, mobile app, or a phone or video visit (where available). Speak with an advice nurse by calling 808-432-0000 (Oahu); 808-243-6000 (Maui/Molokai/Lanai); 808-334-4400 (Hawaii Island); 808-246-5600 (Kauai); (TTY 711). Visit our website & mobile app to email your doctor for nonurgent questions and refill most prescriptions. For refills, you can also call 808-643-7979 (TTY 711), 24/7. Our farmers markets are cancelled until further notice."

During the past decade, Kaiser Permanente Moanalua Medical Center conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 79 clinical trials were completed, i.e. on average, 96.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 41 clinical trials were completed. i.e. 227.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Moanalua Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Moanalua Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Moanalua Medical Center" are "Breast Cancer" (14 trials), "Colorectal Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Stage IIIA Breast Cancer" (6 trials). Many other conditions were trialed in "Kaiser Permanente Moanalua Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Moanalua Medical Center" are "Drug" (135 trials), "Other" (91 trials), "Biological" (56 trials), "Procedure" (40 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (31 trials), "Questionnaire Administration" (20 trials), "Computed Tomography" (17 trials) and "Nivolumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Moanalua Medical Center" are 139 trials for "All" genders, 36 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Moanalua Medical Center". undefined are not yet recruiting, 33 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Kaiser Permanente Moanalua Medical Center, 4 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Moanalua Medical Center, 4 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".